Home
>
National Drug Code (NDC)
>
Avapro
Avapro - 0024-5851-30 - (irbesartan)
Drug Information of Avapro
| Product NDC: | 0024-5851 |
| Proprietary Name: | Avapro |
| Non Proprietary Name: | irbesartan |
| Active Ingredient(s): | 150 mg/1 & nbsp; irbesartan |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Avapro
| Product NDC: | 0024-5851 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020757 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130101 |
Package Information of Avapro
| Package NDC: | 0024-5851-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (0024-5851-30) |
NDC Information of Avapro
| NDC Code | 0024-5851-30 |
| Proprietary Name | Avapro |
| Package Description | 30 TABLET in 1 BOTTLE (0024-5851-30) |
| Product NDC | 0024-5851 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | irbesartan |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130101 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | IRBESARTAN |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
